share_log

Reneo Pharmaceuticals | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

SEC announcement ·  Mar 28 16:10
Summary by Moomoo AI
Reneo Pharmaceuticals, Inc., a biopharmaceutical company, has filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on March 28, 2024. The filing is intended to register additional shares for the company's 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan. Specifically, the registration includes 1,671,040 additional shares for the Equity Incentive Plan and 334,208 additional shares for the Employee Stock Purchase Plan. These shares are intended to support the company's automatic increase provisions in both plans. Reneo Pharmaceuticals has previously registered shares for these plans in filings dating back to April 9, 2021. The company, headquartered in Irvine, California, is categorized as a non-accelerated filer, a smaller reporting company, and an emerging growth company according to SEC definitions.
Reneo Pharmaceuticals, Inc., a biopharmaceutical company, has filed a Registration Statement on Form S-8 with the Securities and Exchange Commission (SEC) on March 28, 2024. The filing is intended to register additional shares for the company's 2021 Equity Incentive Plan and 2021 Employee Stock Purchase Plan. Specifically, the registration includes 1,671,040 additional shares for the Equity Incentive Plan and 334,208 additional shares for the Employee Stock Purchase Plan. These shares are intended to support the company's automatic increase provisions in both plans. Reneo Pharmaceuticals has previously registered shares for these plans in filings dating back to April 9, 2021. The company, headquartered in Irvine, California, is categorized as a non-accelerated filer, a smaller reporting company, and an emerging growth company according to SEC definitions.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Doc 2

Doc 3

Doc 4

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more